Home | Welcome to Contract Pharma   
Last Updated Thursday, July 10 2014
Print RSS Feed

Search Results for 'Novartis, MorphoSys Expand Antibody Alliance'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published November 14, 2012
Incorporates new technology platforms Read More »
Published September 16, 2009
Lisa Rojkjaer, M.D. has been appointed vice president and head of clinical development at MorphoSys. Read More »
Published December 3, 2007
Novartis and MorphoSys AG have formed a comprehensive, 10-year, $600 million strategic alliance for the discovery and development of biopharmaceuticals. The deal is aimed at establishing a pipeline of innovative drugs, and establishes Novartis as Mor… Read More »
Published June 26, 2006
MorphoSys AG expanded its therapeutic antibody collaboration with Novartis. The original collaboration agreement provided for a three-year term with an option for Novartis to extend. The collaboration will now go through May 2011. In May 2004,… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On